| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Jun 24 | Jun 23 | Jun 22 |
| Total Liabilities Shareholders' Equity | 794.20 | 794.36 | 1,101.19 | 888.12 |
| Accumulated Depreciation Total | -109.40 | -96.18 | -120.47 | -130.45 |
| Cash Equivalents | 89.81 | 149.77 | 339.63 | 281.40 |
| Other Liabilities Total | 37.12 | 30.33 | 37.52 | 39.73 |
| Accrued Expenses | 14.74 | 25.94 | 35.31 | 26.93 |
| Common Stock Total | 16.60 | 16.60 | 16.60 | 16.60 |
| Other Current Assets Total | 7.57 | 14.86 | 5.17 | 5.13 |
| Prepaid Expenses | 4.51 | 1.80 | 1.17 | 0.49 |
| Total Assets | 794.20 | 794.36 | 1,101.19 | 888.12 |
| Current Portof LT Debt/ Capital Leases | 2.81 | 2.68 | 3.12 | 2.83 |
| Additional Paid- In Capital | 11.13 | 11.13 | 11.13 | 11.13 |
| Cash | 92.27 | 88.73 | 95.42 | 38.00 |
| Total Equity | 536.96 | 538.24 | 750.89 | 616.49 |
| Long Term Investments | 4.37 | 1.90 | 2.25 | 2.60 |
| Retained Earnings( Accumulated Deficit) | 509.23 | 510.51 | 723.16 | 588.76 |
| Total Common Shares Outstanding | 1.66 | 1.66 | 1.66 | 1.66 |
| Property/ Plant/ Equipment Total- Gross | 231.39 | 227.71 | 293.74 | 280.07 |
| Tangible Book Valueper Share Common Eq | 323.05 | 323.67 | 451.79 | 371.37 |
| Total Liabilities | 257.24 | 256.12 | 350.30 | 271.63 |
| Total Debt | 7.62 | 9.56 | 12.00 | 2.83 |
| Cashand Short Term Investments | 182.08 | 251.87 | 447.61 | 326.86 |
| Total Receivables Net | 222.11 | 145.08 | 201.19 | 157.94 |
| Notes Payable/ Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Accounts Receivable- Trade Net | 145.52 | 85.33 | 115.71 | 83.44 |
| Property/ Plant/ Equipment Total- Net | 121.99 | 131.53 | 173.27 | 149.62 |
| Total Current Liabilities | 215.31 | 218.91 | 303.90 | 231.90 |
| Total Inventory | 110.12 | 110.61 | 140.96 | 117.62 |
| Accounts Payable | 171.60 | 167.00 | 237.04 | 172.08 |
| Other Currentliabilities Total | 26.16 | 23.29 | 28.43 | 30.06 |
| Total Long Term Debt | 4.81 | 6.88 | 8.88 | 0.00 |
| Intangibles Net | 0.71 | 0.96 | 0.94 | 0.04 |
| Other Long Term Assets Total | 39.85 | 39.93 | 30.41 | 28.41 |
| Note Receivable- Long Term | 100.89 | 95.82 | 98.22 | 99.41 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 526.39 | 524.22 | 796.10 | 608.04 |
| Capital Lease Obligations | 4.81 | 6.88 | 8.88 | 0.00 |
| Short Term Investments | - | 13.37 | 12.56 | 7.46 |
Procter & Gamble Health Dividend Procter & Gamble Health Bonus Procter & Gamble Health News Procter & Gamble Health AGM Procter & Gamble Health Rights Procter & Gamble Health Splits Procter & Gamble Health Board Meetings Procter & Gamble Health Key Metrics Procter & Gamble Health Shareholdings Procter & Gamble Health Profit Loss Procter & Gamble Health Cashflow Procter & Gamble Health Q1 Results Procter & Gamble Health Q2 Results Procter & Gamble Health Q3 Results Procter & Gamble Health Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks